OBJECTIVE: To analyze the success rates and prognosis of heart valvuloplasty and valve replacement for elderly @entity1 , and to provide clinical evidence. METHODS: A total of 1240 @entity1 who received heart valve surgeries in our hospital from June 2004 to October 2014 were selected and retrospectively analyzed. They were divided into two groups based on age (60), and those older than 60 (Group B) suffered from @entity340 and nonrheumatic @entity340 including @entity179 . Mitral valve replacement (MVR), tricuspid valve replacement (TVR), @entity886 ( @entity886 ), double valve replacement (DVR), @entity339 ( @entity339 ) and tricuspid valvuloplasty (TVP) were performed by using bioprosthetic and mechanical valves. Before surgery, coronary angiography, coronary artery bypass grafting (CABG), left @entity955 , left atrial wall folding and radiofrequency ablation were conducted. For the @entity1 younger than 60 (Group A) who had @entity299 , @entity340 and @entity340 , MVR, @entity886 , DVR, @entity339 , TVP and closed cuspid commissurotomy were performed with bioprosthetic and mechanical valves. The two groups were then monitored. RESULTS: The mortality rates of Group A and Group B were 2.7% (16 cases) and 3.1% (20 cases) respectively. They died mainly of malignant @entity943 , @entity881 , left @entity9009 , @entity998 , @entity810 , @entity1576 , upper @entity360 , mechanical valve failure and cerebrovascular accident. The two groups had significantly different application rates of bioprosthetic valve, times of auxiliary ventilation and hospitalization stay lengths (P<0.05), but left ventricular ejection fractions, left ventricular end-diastolic diameters (LVEDDs), mortality rates as well as times of aortic cross-clamping and cardiopulmonary bypass were similar (P>0.05). LVEDD, complicated @entity453 , CABG and grade of the New York Heart Association Functional Classification were independent risk factors for @entity204 . CONCLUSION: When heart valvuloplasty and valve replacement were performed for elderly @entity1 , the success rate and prognosis could only be improved by optimizing preoperative preparation, shortening the times of cardiopulmonary bypass and aortic cross-clamping, and paying particular attention to myocardial protection and postoperative treatment.

Success rates and prognosis of heart valvuloplasty and valve replacement performed for elderly XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity339 :: ('MESH:D008944', 'Disease') :: ['MVP', 'mitral valvuloplasty'] @entity9009 :: ('MESH:D018658', 'Disease') :: ['ventricular rupture'] @entity998 :: ('MESH:D002303', 'Disease') :: ['low cardiac output syndrome'] @entity886 :: ('MESH:C563178', 'Disease') :: ['AVR', 'aortic valve replacement'] @entity881 :: ('MESH:D009102', 'Disease') :: ['multiple organ failure'] @entity179 :: ('MESH:D019636', 'Disease') :: ['degenerative valve disease'] @entity1576 :: ('MESH:D012131', 'Disease') :: ['respiratory failure'] @entity955 :: ('MESH:D001281', 'Disease') :: ['atrial thrombectomy'] @entity299 :: ('MESH:D006331', 'Disease') :: ['congenital heart disease'] @entity810 :: ('MESH:D058186', 'Disease') :: ['acute renal failure'] @entity453 :: ('MESH:D003324', 'Disease') :: ['coronary artery disease'] @entity340 :: ('MESH:D006349', 'Disease') :: ['rheumatic valvular heart disease', 'valvular heart disease'] @entity943 :: ('MESH:D001145', 'Disease') :: ['ventricular arrhythmias'] @entity360 :: ('MESH:D006471', 'Disease') :: ['gastrointestinal bleeding'] @entity204 :: ('MESH:D003643', 'Disease') :: ['postoperative death']
@entity1 :: (9606,Species) :: ['patients']
